Table 1.
Demographics | N. | % |
---|---|---|
Male | 55 | 57.3 |
Female | 41 | 42.7 |
Mean Age (years) | 52.2 (26–81) | |
Mean tumor diameter (mm) | 46.5 (41–61) | |
KNOSP Classification | ||
Grade 0 | 30 | 31.2 |
Grade 1 | 24 | 25.0 |
Grade 2 | 19 | 19.8 |
Grade 3 | 9 | 9.4 |
Grade 4 | 14 | 14.6 |
Endocrinological status | ||
Non-functioning | 96 | 100 |
Preoperative Clinical symptoms and signs | ||
Visual field defects | 78 | 81.2 |
Anterior pituitary insufficiency | 53 | 55.2 |
Headache | 12 | 12.5 |
Visual acuity deficit | 9 | 9.4 |
Drowsiness | 3 | 3.1 |
Treatment | ||
EEA-TTP 1 | 96 | 100 |
GPA consistency | ||
Soft | 50 | 52.1 |
Firm/fibrous | 46 | 47.9 |
GPA vascularization | ||
Significant | 31 | 32.3 |
Not significant | 65 | 67.7 |
Extent of resection | ||
GTR 2 (100%) | 34 | 35.4 |
NTR 3 (96 to 99%) | 12 | 12.5 |
STR 4 (75 to 95%) | 50 | 52.1 |
Clinical outcome | ||
Visual improvement | 77 | 98.7 |
Recovery of pituitary function | 27 | 50.9 |
Surgical complications | ||
CSF 5 leak | 7 | 7.3 |
Meningitis | 7 | 7.3 |
Apoplexy of residual tumor | 2 | 2.1 |
Hydrocephalus | 1 | 1.0 |
Right eye Blindness | 1 | 1.0 |
Transient DI | 37 | 37.5 |
Transient delayed hyponatremia | 20 | 20.8 |
Progression | ||
Yes | 16 | 16.7 |
No | 80 | 83.3 |
Treatment of 16 recurrences | ||
Re-do EEA-TTP | 3 | 3.1 |
GKRS 6 | 4 | 4.2 |
SRT 7 | 9 | 9.4 |
1 EEA-TTP, extended endoscopic approach transtuberculum/transplanum. 2 GTR, gross total removal. 3 NTR, near total removal. 4 STR, subtotal removal. 5 CSF, cerebrospinal fluid. 6 GKRS, gamma-knife radiosurgery. 7 SRT, stereotactic radiotherapy.